|
ATM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.437800E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.522300E-02 |
| Normal-vs-Stage2 |
3.558200E-02 |
| Normal-vs-Stage3 |
3.829600E-01 |
| Normal-vs-Stage4 |
9.934600E-01 |
| Stage1-vs-Stage2 |
2.024600E-01 |
| Stage1-vs-Stage3 |
5.237800E-01 |
| Stage1-vs-Stage4 |
3.494600E-01 |
| Stage2-vs-Stage3 |
1.235020E-01 |
| Stage2-vs-Stage4 |
1.359370E-01 |
| Stage3-vs-Stage4 |
5.911400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.636300E-03 |
| Normal-vs-AfricanAmerican |
6.615800E-02 |
| Normal-vs-Asian |
9.366800E-01 |
| Caucasian-vs-AfricanAmerican |
7.613600E-01 |
| Caucasian-vs-Asian |
4.576600E-01 |
| AfricanAmerican-vs-Asian |
5.533000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.829500E-02 |
| Normal-vs-Female |
3.222600E-04 |
| Male-vs-Female |
1.636390E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.178240E-01 |
| Normal-vs-Extreme_Weight |
2.104400E-01 |
| Normal-vs-Obese |
3.496200E-03 |
| Normal-vs-Extreme_Obese |
6.393000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.237000E-01 |
| Normal_Weight-vs-Obese |
2.526400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.001800E-01 |
| Extreme_Weight-vs-Obese |
6.422100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.104600E-01 |
| Obese-vs-Extreme_Obese |
3.188000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.807980E-02 |
| Normal-vs-Age(41-60Yrs) |
2.200900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.427600E-01 |
| Normal-vs-Age(81-100Yrs) |
6.325000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.112400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.130300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.224550E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.015500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.049200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.405200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.972300E-04 |
| Normal-VS-Type2 PRCC |
9.100000E-01 |
| Normal-VS-KIRP CIMP |
1.928590E-01 |
| Normal-VS-Unclassified PRCC |
6.598900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.993800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.506600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.697600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.672100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.760800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.211000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.953200E-01 |
| Normal-vs-N1 |
2.664400E-01 |
| Normal-vs-N2 |
1.350840E-01 |
| N0-vs-N1 |
6.698400E-01 |
| N0-vs-N2 |
1.223450E-03 |
| N1-vs-N2 |
6.281300E-03 |
|
|
